Current Nanomaterials
Title:Meet Our Editorial Board Member
Volume: 3 Issue: 2
Author(s): Rouhollah Azimirad
Affiliation:
Export Options
About this article
Cite this article as:
Azimirad Rouhollah , Meet Our Editorial Board Member, Current Nanomaterials 2018; 3 (2) . https://dx.doi.org/10.2174/240546150302181024141943
DOI https://dx.doi.org/10.2174/240546150302181024141943 |
Print ISSN 2405-4615 |
Publisher Name Bentham Science Publisher |
Online ISSN 2405-4623 |
Call for Papers in Thematic Issues
?Recent Advances in Design, Characterizations, Applications and Future Prospective of Smart Nanomaterials?
Scope of the Thematic Issue: Smart materials are the family of materials (hydrogels, nitinol, electroactive polymer, graphene structures, carbon-metal nanohybrids ?many more) which represent their significant electrical, catalytic, thermal, optical, mechanical and magnetic properties. There are various numbers of categorized smart nanomaterials materials reported so far such as thermoresponsive, piezoelectric, ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application
Current Drug Research Reviews A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2
Combinatorial Chemistry & High Throughput Screening Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer
Current Drug Targets Synthesis and Antimicrobial Activities of Hybrid Heterocyclic Molecules Based on 1-(4-Fluorophenyl)piperazine Skeleton
Letters in Drug Design & Discovery The GABA Transporter and its Inhibitors
Current Medicinal Chemistry Ivermectin in COVID-19 Management: What is the Current Evidence?
Infectious Disorders - Drug Targets Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19
Cardiovascular & Hematological Disorders-Drug Targets Curcumin-Based Anti-Prostate Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Central Nervous System-Related
Current Bioactive Compounds Withdrawal Notice: Recent Developments in Anti-Cancer Activity of Compounds Containing the Thioether Group
Anti-Cancer Agents in Medicinal Chemistry 20th National Congress and Conference Abstracts
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Progress Towards Pharmaceutical Applications of Disulfide-Rich Cyclic Peptides
Current Protein & Peptide Science The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases - Part II
Current Medicinal Chemistry Clinical Characteristics and CT Imaging Features of COVID-19 on Admission: A Retrospective Study
Current Medical Imaging Antimitotic Peptides and Depsipeptides
Current Medicinal Chemistry - Anti-Cancer Agents Molecular Docking and Dynamics Simulation of Natural Phenolic Compounds with GSK-3β: A Putative Target to Combat Mortality in Patients with COVID-19
Recent Advances in Inflammation & Allergy Drug Discovery Design and Screening Strategies for α-Glucosidase Inhibitors Based on Enzymological Information
Current Topics in Medicinal Chemistry Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Computational Design, Organic Synthesis, and Biological Evaluation of Polyphenol Proteasome Inhibitors: Significance in Drug Discovery and Cancer Prevention
Drug Design Reviews - Online (Discontinued)